Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein (HSIC) delivers essential healthcare products and services to dental, medical, and animal health practices worldwide. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives.
Track all official announcements through our curated collection of press releases and verified news coverage. Stay informed about earnings reports, product launches, partnership agreements, and operational milestones that shape Henry Schein's position in global healthcare distribution.
Key updates include acquisitions expanding service capabilities, technological innovations in supply chain management, and regulatory developments affecting medical device distribution. Our repository eliminates fragmented research by consolidating critical information from multiple sources.
Bookmark this page for efficient monitoring of HSIC's market activities. Return regularly to access new filings, leadership updates, and analysis of trends impacting healthcare providers and distributors.
Henry Schein, Inc. (Nasdaq: HSIC) has launched 'Prepare to Care', an initiative of the Henry Schein Cares Foundation (HSCF) to enhance emergency preparedness and relief efforts. The program involves pre-positioning health care supplies and cash donations with five trusted NGO relief agency partners: Americares, Direct Relief, Heart to Heart International, Project C.U.R.E., and Project HOPE.
Each partner will receive a $10,000 cash grant and the ability to select $25,000 in essential health care products from the Henry Schein Brand Products catalog. These resources will be strategically located at partner warehouses for rapid deployment to areas of need. The initiative aims to improve response times during emergencies, supporting health care professionals in providing critical care.
Henry Schein (Nasdaq: HSIC) has been named to FORTUNE® magazine's 'Change the World' list for its innovative emergency preparedness and response strategy supporting healthcare professionals and communities globally. The company's approach includes:
1. Donating and pre-positioning supplies
2. Partnering with stakeholders on disaster response
3. Catalyzing public-private partnerships
4. Supporting healthcare professionals
This marks Henry Schein's fourth appearance on the list, previously recognized for expanding access to oral health care (2018), co-founding the Pandemic Supply Chain Network (2020), and advancing health equity for individuals with disabilities (2022). The 'Change the World' list celebrates companies that align business strengths with societal needs to effect positive change.
CareQuest Innovation Partners, Colgate-Palmolive Company, Henry Schein, and PDS Health are partnering to create the first-ever Oral Health Pavilion at HLTH 2024. This initiative aims to spotlight the connection between oral health and overall health, showcasing innovation in clinical practice and preventive self-care.
The pavilion will demonstrate the dental practice of the future, highlighting medical-dental integration and its potential to improve patient care, reduce costs, and enhance health equity. Attendees will experience various stages of a patient's oral health journey, including minimally invasive treatments and at-home solutions.
The event will also feature a 'Demo Day' showcasing innovative startups from CareQuest's SMILE Health accelerator. Industry panels will discuss the importance of integrating oral health into primary care and potential solutions for current healthcare challenges.
Henry Schein (Nasdaq: HSIC) has secured an exclusive distribution agreement with Swiss company vVARDIS for their Curodont™ Repair Fluoride Plus product to larger dental service organizations (DSOs) in the U.S. This innovative, drill-free solution addresses early-stage tooth decay, aiding in preventive treatment of cavity progression.
The partnership aims to expand patient care with a non-invasive approach, as nearly 80% of patients show signs of early decay. Henry Schein's CEO, Stanley M. Bergman, emphasized the product's ability to treat early-stage caries non-invasively and on the same day. The agreement complements Henry Schein One's Dentrix® Detect AI, an AI-enabled X-ray analysis tool introduced in late 2022, which can detect incipient carious lesions more accurately than the naked eye.
Henry Schein (Nasdaq: HSIC) will participate in the FDI World Dental Congress 2024 in Istanbul, Turkey, from September 12-15, 2024. Key highlights include:
1. Unveiling of FDI's Electronic Health Record (EHR) Task Team's Consensus Statement on EHR interoperability.
2. Presentation on 'Interprofessional Collaboration: Reforming Health Systems Through Electronic Health Records' by Dr. Ryan Hungate, Chief Clinical Officer at Henry Schein One.
3. Second edition of the Young Dentists Forum, supporting the next generation of dental professionals.
4. Full-day learning and networking session by the FDI Section of Women Dentists Worldwide.
5. Panel discussion on the economic benefits of investing in oral health, as part of the World Economic Forum's Oral Health Affinity Group initiative.
Henry Schein One has introduced two new insurance eligibility verification tools for dental practices: Eligibility Essentials and Eligibility Pro. These solutions are designed to simplify the insurance verification process, reducing administrative burden and enhancing patient care.
Eligibility Essentials streamlines access to accurate insurance data within Dentrix, while Eligibility Pro provides additional benefits data from payor portals. Both tools aim to save time for dental staff by eliminating the need for manual data gathering and portal logins.
The new offerings are expected to improve treatment plan acceptance by providing patients with better understanding of their coverage and out-of-pocket expenses. Beta testing at Dawson Family Dentistry has shown positive results, with patient processing time cut in half and improved workflow efficiency.
Henry Schein (Nasdaq: HSIC), the National Dental Association, and the Schattner Foundation completed the second year of their S.M.I.L.E. Healthcare Pathway Program. This initiative aims to inspire students from underrepresented backgrounds to pursue dental careers. The 2024 program, held at Meharry Medical College School of Dentistry, included 35 ninth and tenth-grade students from diverse backgrounds.
The program expanded to include Hispanic, Alaska Native, American Indian, and Indigenous students. It offered mentorship, hands-on learning, career exposure, and a capstone project. The initiative addresses the disparity in dental workforce diversity, with Black or African American dentists representing only 3.8% of the total, despite making up 14% of the general population.
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in two upcoming investor conferences in September 2024:
- The Morgan Stanley 22nd Annual Global Healthcare Conference in New York on September 5, 2024, at 11:30 a.m. Eastern time.
- The Baird 2024 Global Healthcare Conference in New York on September 10, 2024, at 10:15 a.m. Eastern time.
Interested parties can access live webcasts of Henry Schein's presentations at www.henryschein.com/IRwebcasts. Replays will be available on the company's website following the presentations.
Henry Schein (Nasdaq: HSIC) has launched its 27th annual 'Back to School' program, a global initiative under Henry Schein Cares. This year, Team Schein Members at 40 locations across the U.S., Canada, U.K., and Ireland are helping 5,300 students prepare for the academic year. The program involves packing backpacks with school supplies and dental kits for underserved children.
On August 7, the company hosted an event at its Melville, N.Y. headquarters, providing 400 pre-identified children with backpacks, gift cards for school outfits, and various activities. Since its inception in 1998, the program has served over 65,000 children globally. Henry Schein partnered with 10 Long Island-based social service organizations for the Melville event, demonstrating its commitment to educational equity and community support.
Henry Schein (Nasdaq: HSIC) reported Q2 2024 financial results with total net sales of $3.1 billion, up 1.1% from Q2 2023. GAAP diluted EPS was $0.80, while non-GAAP diluted EPS reached $1.23. The company updated its 2024 guidance, now expecting total sales growth of 4% to 6% and non-GAAP diluted EPS between $4.70 and $4.82. Henry Schein announced a new restructuring plan targeting $75-$100 million in annual run-rate savings and increased its share repurchase authorization by $500 million. The company reported strong operating cash flow of $296 million for Q2 and $493 million year-to-date, up $192 million compared to 2023.